I don&#x27;t have a horse in the race. I just think you&#x27;re not reading these documents carefully or considering the evidence carefully.<p>For example, that case you cite above, the $6k copay. OK. Read the memo closely. A Walgreens exec is emailing a Turing exec citing a patient&#x27;s problem with Turing&#x27;s bureaucracy.<p>How was the problem resolved? Did Turing pay? You say that CLEARLY Turing didn&#x27;t end up paying in this particular case, because you hate Turing, but the document doesn&#x27;t say. And you have no idea. Neither do I, but I&#x27;m not pretending.<p>Generally: Turing says, for goodwill, they give away 60% of the drug for a dollar.<p>Do you know of even one case where someone - verifiably - fell through the cracks and Turing refused to EVER pay?<p>Are you opposed to the idea of pharmaceutical companies selling orphan drugs at high prices ($100k, $300k, or more)? Or are you only opposed to Turing&#x27;s purchase of Daraprim and raising the price? Would you still oppose them if, in 10 years, it turned out Turing&#x27;s profits had, e.g., produced a PKAN drug? Do you know a better way than high drug prices to incentivize the creation of drugs for serious rare diseases?